MACH32 INC.
$188,500.00 CAD
≈ 2 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2026-2027
- Agreement period
- June 1, 2026 – May 31, 2027
- Reference
- nrc-cnrc:172-2026-2027-Q1-1043943
Published purpose
MACH32 Inc. is developing a novel drug-device combination comprising an autoinjector for the intramuscular (IM) administration of a proprietary formulation of concentrated Tranexamic acid (TXA) drug for treatment of trauma-related bleeding. This proposed project supports the development and commercialization of Firm’s TXA products.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 10, 2026 from open.canada.ca Grants & Contributions